[IKT] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
31-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -12.77%
YoY- -317.38%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 0 7 46 2 328 1,363 1,407 -
PBT -4,495 -4,640 -4,641 -5,042 -4,471 -2,636 -2,637 42.65%
Tax 0 -4,640 -4,641 -0 -4,471 -2,628 -2,625 -
NP -4,495 -4,640 -4,641 -5,042 -4,471 -2,636 -2,637 42.65%
Tax Rate - - - - - - - -
Total Cost 4,495 4,646 4,687 5,044 4,800 3,999 4,044 7.29%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 0.00 -70,817.14 -10,081.47 -259,342.54 -1,361.26 -193.40 -187.40 -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -1.06 -1.10 -1.10 -1.20 -1.07 -1.29 -1.57 -23.02%
EPS Diluted -1.06 -1.10 -1.10 -1.20 -1.07 -1.29 -1.57 -23.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.